Targeting herpes simplex virus with CRISPR–Cas9 cures herpetic stromal keratitis in mice
Cited by 178
Related Papers
Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers
|Nature Biomedical Engineering|2024|89
Modified lentiviral globin gene therapy for pediatric β0/β0 transfusion-dependent β-thalassemia: A single-center, single-arm pilot trial
|Cell stem cell|2024|77
Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy
|Nature Nanotechnology|2025|63
A single dose SARS-CoV-2 simulating particle vaccine induces potent neutralizing activities
|bioRxiv (Cold Spring Harbor Laboratory)|2020|10
Immunostimulatory guide RNAs mediate potent antiviral response
|bioRxiv (Cold Spring Harbor Laboratory)|2018|2